Regulation of antioxidant enzymes: A significant role for melatonin

Journal of Pineal Research

Volumn 36, Issue 1, 2004, Pages 1-9

  Rodriguez, Carmen ^a,b,d   Mayo, Juan C ^a,c   Sainz, Rosa M ^b,c   Antolín, Isaac ^a   Herrera, Federico ^a   Martín, Vanesa ^a   Reiter, Russel J ^c  

^a Facultad de Medicina   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Faculty de Medicina   (Spain)

Author keywords

Antioxidant enzyme activity; Antioxidant enzyme gene expression; Antioxidant enzymes; Melatonin; Regulation

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MELATONIN; MESSENGER RNA; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; CANCER INHIBITION; DRUG MEGADOSE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GENE EXPRESSION; GENOMICS; HUMAN; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REGULATORY MECHANISM; SHORT SURVEY;

ANIMALS; ANTIOXIDANTS; CATALASE; ENZYMES; GLUTATHIONE PEROXIDASE; HUMANS; MELATONIN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 1642562820     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-079X.2003.00092.x     Document Type: Short Survey

References (130)

1. HALLIWELL B. Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 1991; 91:3C14S-3C22S.
2. HALLIWELL B, GUTTERIDGE MC. Biologically relevant metal ion-dependent hydroxyl radical generation. FEBS Lett 1992; 307:108-112.
3. HALLIWELL B, GUTTERIDGE MC. The chemistry of oxygen radicals and other oxygen-derived species. In: Free Radicals in Biology and Medicine. Halliwell B, Gutteridge JMC, eds., Clarendon Press, Oxford, 1985; pp. 20-66.
4. HALLIWELL B. Oxidants and human disease: some new concepts. FASEB J 1987; 1:358-364.
5. GUTTERIDGE MC. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann N Y Acad Sci 1994; 51:288-295.
6. FEIG DI, REID TM, LOEB LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54:1890-1894.
7. MATES JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153:83-104.
8. PAHL HL, BAERERLE PA. Oxygen and the control of gene expression. BioEssays 1994; 16:497-502.
9. WARNER BB, STUART L, GEBB S, WISPE JR. Redox regulation of manganese superoxide dismutase. Am J Physiol 1996; 271:L150-158.
10. FRANCO AA, ODOM RS, RANDO TA. Regulation of antioxidant enzymes gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle. Free Rad Biol Med 1999; 50:2093-2098.
11. NICOTERA TM, NOTARO J, NOTARO S et al. Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res 1989; 49:5239-5243.
12. YOO HY, CHANG MS, RHO HM. The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 1999; 274:23,887-23,892.
13. KIM HP, ROE JH, CHOCK PB, YIM MB. Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetate. J Biol Chem 1999: 274:37,455-37,460.
14. HAYASHIBE H, ASAYAMA K, DOBASHI K, KATO K. Prenatal development of antioxidant enzymes in rat lung, kidney, and heart: marked increase in immunoreactive superoxide dismutases, glutathione peroxidase and catalase in the kidney. Pediatr Res 1990; 27:472-475.
15. WAF1 and p53 expression during proliferation and differentiation of human melanoma cell lines. Free Rad Biol Med 1999; 26:1027-1033.
16. VANELLA A, VILLA RF, GORINI A et al. Superoxide dismutase and cytochrome oxidase activities in light and heavy synaptic mitochondria from rat cerebral cortex during aging. J Neurosci Res 1989; 22:351-355.
17. KASAPOGLU M, OZBEN T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 2001; 36:209-220.
18. WEI YH, LEE HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227:671-682.
19. JONES PL, PING D, BOSS JM. Tumor necrosis factor alpha and interleukin-1β regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-β and NF-κB. Mol Cell Biol 1997; 17: 6970-6981.
20. ROGERS RJ, CHESROWN SE, KUO S et al. Cytokine-inducible enhancer with promoter activity in both the rat and human manganese-superoxide dismutase genes. Biochem J 2000; 347:233-242.
21. DOUGALL WC, NICK HS. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology 1991; 129:2376-2384.
22. SAMPATH D, PEREZ-POLO R. Regulation of antioxidant enzyme expression by NGF. Neurochem Res 1997; 22:351-362.
23. SUGINO N, HIROSAWA-TAKAMORI M, ZHONG L et al. Hormonal regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase messenger ribonucleic acid in the rat corpus luteum: induction by prolactin and placental lactogens. Biol Rept 1998; 59:599-605.
24. ANTOLIN I, RODRIGUEZ C, SAINZ RM et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996; 10:882-890.
25. MAYO JC, SAINZ RM, URÍA H et al. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 1998; 24:179-192.
26. LU CK, KO YJ, CHIANG MT et al. Effect of dietary vitamin E on antioxidant status and antioxidant enzyme activities in Sprague-Dawley rats. Nutr Cancer 1998; 32:95-100.
27. OZTURK-UREK R, BOZKAYA LA, TARHAN L. The effects of some antioxidant vitamin- and trace element-supplemented diets on activities of SOD, CAT, GSH-Px and LPO levels in chicken tissues. Cell Biochem Funct 2001; 19:125-132.
28. NAGATA H, TAKEKOSHI S, TAKAGI T et al. Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase. Tokai J Exp Med 1999; 24:1-11.
29. 2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 1996; 271:24,539-24,543.
30. CASSONE VM. Effects of melatonin on vertebrate circadian systems. Trends Neurosci 1990; 13:457-464.
31. BLASK DE, HILL SM, ORSTEAD KM, MASSA JS. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis. J Neural Transm 1986; 67:125-138.
32. MAESTRONI GJ, CONTI A, PIERPAOLI W. Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism. Clin Exp Immunol 1987; 68:384-391.
33. TAN DX, CHEN DX, POEGGELER B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
34. TAN DX, POEGGELER B, REITER RJ et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993; 70:65-71.
35. STEINHILBER D, BRUNGS M, WERZ O et al. The nuclear receptor for melatonin repress 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995; 270:7037-7040.
36. REITER RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9:526-533.
37. REITER RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
38. REITER RJ, MAESTRONI G. Melatonin in relation to the antioxidative defense and immune systems: possible implications for cell and organ transplantation. J Mol Med 1999; 77:36-39.
39. KARBOWNIK M, REITER RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225:9-22.
40. REITER RJ, TAN DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58:10-19.
41. ALLEGRA M, REITER RJ, TAN D-X et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
42. MENENDEZ-PELAEZ A, RODRIGUEZ C, DOMINGUEZ P. 5-Aminolevulinatesynthase mRNA levels in the Harderian glands of Syrian hamsters: correlation with porphyrin concentrations and regulation by androgens and melatonin. Mol Cell Endocrinol 1991; 80:177-182.
43. MENENDEZ-PELAEZ A, POEGGELER B, REITER RJ et al. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53:373-382.
44. RODRIGUEZ C, KOTLER M, MENENDEZ-PELAEZ A et al. Circadian rhythm in 5-aminolevulinate synthase mRNA levels in the Harderian gland of the Syrian hamster: involvement of light:dark cycle and pineal function. Endocrine 1994; 2:863-868.
45. MOLIS TM, SPRIGGS LL, HILL SM. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994; 8:1681-1690.
46. WAJS E, KUTOH E, GUPTA D. Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat. Eur J Endocrinol 1995; 133:754-760.
47. REITER RJ, OH C-S, FUJIMORI O. Melatonin. Its intracellular and genomic actions. Trends Endocrinol Metab 1996; 7:22-27.
48. RODRIGUEZ C, KOTLER M, ANTOLÍN I et al. Regulation of the aminolevulinate synthase gene in the Syrian hamster Harderian gland: changes during development and circadian rhythm and role of some hormones. Micro Res Technique 1996; 34:65-70.
49. LI S, GIVALOIS L, PELLETIER G. Effects of aging and melatonin administration on gonadotropin-releasing hormones (GnRH) gene expression in the male and female rat. Peptides 1997; 18:1023-1028.
50. TANG YP, MA YL, CHAO CC et al. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments. J Neurosci Res 1998; 53:593-604.
51. SAINZ RM, MAYO JC, KOTLER M et al. Melatonin decreases mRNA for histone H4 in thymus of young rats. Life Sci 1998; 63:1109-1117.
52. KOTLER ML, RODRIGUEZ C, SAINZ RM et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24:83-89.
53. SAINZ RM, MAYO JC, REITER RJ et al. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J 1999; 13:1547-1556.
54. CRESPO E, MACIAS M, POZO D et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13:1537-1546.
55. WON JS, SONG DK, HUH SO et al. Effect of melatonin on the regulation of proenkephalin and prodynorphin mRNA levels induced by kainic acid in the rat hippocampus. Hippocampus 2000; 10:236-243.
56. ROY D, BELSHAM DD. Melatonin receptor activation regulates GnRH gene expression and secretion in GT1-7 GnRH neurons. Signal transduction mechanisms. J Biol Chem 2002; 277:251-258.
57. SHARMAN KG, SHARMAN EH, YANG E, BONDY SC. Dietary melatonin selectively reverses age-related changes in cortical cytokine mRNA levels, and their responses to an inflammatory stimulus. Neurobiol Aging 2002; 23:633-638.
58. POZO D, GUERRERO JM, CALVO JR. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1 alpha production and mRNA expression. Cytokine 2002, 18:35-42.
59. BARLOW-WALDEN LR, REITER RJ, ABE M et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995: 26:497-502.
60. PABLOS MI, AGAPITO MT, GUTIERREZ R et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19:111-115.
61. OZTURK G, COSKIN S, ERBAS D, HASANOGLU E. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol 2000; 50:149-153.
62. LIU F, NG TB. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol 2000; 78:447-453.
63. DIAZ-MUÑOZ M, HERNANDEZ-MUÑOZ R, SUAREZ J, CHAGOYA DE SANCHEZ V. Day-night cycle of lipid peroxidation in rat cerebral cortex and their relationship to the glutathione cycle and superoxide dismutase activity. Neuroscience 1985; 16:859-863.
64. ALBARRAN MT, LOPEZ-BURILLO S, PABLOS MI et al. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light. J Pineal Res 2001; 30:227-233.
65. MARTIN V, SAINZ RM, MAYO JC et al. Daily rhythm of gene expression in rat superoxide dismutases. Endocrine Res 2003; 29:83-95.
66. PABLOS MI, REITER RJ, ORTIZ GG et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int 1998; 32:69-75.
67. TUNEZ I, MUÑOZ MC, FEIJOO M et al. Melatonin effect on renal oxidative stress under constant light exposure. Cell Biochem Funct 2003; 21:35-40.
68. TOMAS-ZAPICO C, COTO-MONTES A, MARTINEZ-FRAGA J et al. Effects of continuous light exposure on antioxidant enzymes, porphyric enzymes and cellular damage in the Harderian gland of Syrian hamster. J Pineal Res 2003; 34:60-68.
69. BAYDAS G, GURSU MF, YILMAZ S et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett 2002; 323:195-198.
70. OKATANI Y, WAKATSUKI A, KANEDA C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000; 28:89-96.
71. OKATANI Y, WAKATSUKI A, SHINOHARA K et al. Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res 2001; 30:199-205.
72. MAYO JC, SAINZ RM, ANTOLIN I et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59:1706-1713.
73. GECHEV T, GADJEV I, VAN BREUSEGEM F et al. Hydrogen peroxide protects tobacco from oxidative stress by inducing a set of antioxidant enzymes. Cell Mol Life Sci 2002; 59:708-714.
74. MORI W, AOYAMA H, MORI N. Melatonin protects rats from injurious effects of a glucocorticoid, dexamethasone. Jpn J Exp Med 1984; 54:255-261.
75. AOYAMA H, MORI W, MORI N. Anti-glucocorticoid effects of melatonin in young rats. Acta Pathol Jpn 1986; 36:423-428.
76. SANDYK R, KAY SR. The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome. Int J Neurosci 1991; 58:215-247.
77. BURNS JK. Administration of melatonin to non-human primates and to women with breast carcinoma. J Physiol 1973; 229:38P-39P.
78. EL-DOMEIRI AA, Das Gupta TK. Reversal by melatonin of the effect of pinealectomy on tumor growth. Cancer Res 1973; 33:2830-2833.
79. PIERPAOLI W, YI C. The involvement of pineal gland and melatonin in immunity and aging. I. Thymus-mediated, immunoreconstituting and antiviral activity of thyrotropin-releasing hormone. J Neuroimmunol 1990; 27:99-109.
80. REITER RJ. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review. Brazal J Med Biol Res 1993; 26:1141-1155.
81. PIERREFICHE G, TOPALL G, COURBOIN G et al. Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 1993; 80:211-223.
82. JAHOVIC N, CEVIK H, OZER SEHIRILI A, YEGEN BC, SENER G. Melatonin prevents methotrerate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34:282-293.
83. JAWOREK J, LEJA-SZPAK A, BONIOR J et al. Protective effects of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34:40-52.
84. REITER RJ, SAINZ RM, LOPEZ-BURILLO S, MAYO JC, MANCHESTER LC, TAN DX. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann NY Acad Sci 2003; 993:35-47.
85. GITTO E, KARBOWNIK M, REITER RJ et al. Effects of melatonin treatment in septic newborns. Pediat Res 2001; 50:756-760.
86. GITTO E, REITER RJ, CORDARO SP et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melalonin. Am J Perinatol in press.
87. CAGNOLI CM, ATABAY C, KHARLAMOVA E, MANEY H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995; 18:222-226.
88. ABE M, REITER RJ, ORHII PB et al. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994; 17:94-100.
89. PENTNEY PT, BUBENIK GA. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995; 19:31-39.
90. SEWERYNEK E, ABE M, REITER RJ et al. Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem 1995; 58:436-444.
91. MILLER JW, SELHUB J, JOSEPH JA. Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin. Free Rad Biol Med 1996; 21:241-249.
92. SHEN YX, XU SY, WEI W et al. The protective effects of melatonin from oxidative damage induced by amyloid beta-peptide 25-35 in middle-aged rats. J Pineal Res 2002; 32:85-89.
93. SHEN YX, XU SY, WEI W et al. Melatonin reduces memory changes and neuronal oxidative damage in mice treated with D-galactose. J Pineal Res 2002; 32:173-178.
94. NAIDU PS, SING A, KAUR P et al. Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia. Pharmacol Biochem Behav 2003; 74:641-648.
95. WAKATSUKI A, OKATANI Y, SHINOHARA K et al. Melatonin protects fetal rat brain against oxidative mitochondrial damage. J Pineal Res 2001; 30:22-28.
96. OKATANI Y, WAKATSUKI A, REITER RJ, MIYAHARA Y. Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse. Neurobiol Aging 2002; 23:639-644.
97. MEKI AR, HUSSEIN AA. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp Biochem Physiol C Toxicol Pharmacol 2001; 130:305-313.
98. EL-SOKKARY GH, OMAR HM, HASSANEIN AF et al. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Rad Biol Med 2002; 32:319-332.
99. HSU CH, CHI BC, LIU MY et al. Phosphine-induced oxidative damage in rats: role of glutathione. Toxicology 2002; 179:1-8.
100. USTUNDAG B, KAZEZ A, DEMIRBAG M et al. Protective effect of melatonin on antioxidative system in experimental ischemia-reperfusion of rat small intestine. Cell Physiol Biochem 2000; 10:229-236.
101. CABEZA J, MOTILVA V, MARTIN MJ, DE LA LASTRA CA. Mechanisms involved in gastric protection of melatonin against oxidant stress by ischemia-reperfusion in rats. Life Sci 2001; 68:1405-1415.
102. OTHMAN AI, EL-MISSIRY MA, AMER MA. The protective action of melatonin on indomethacin-induced gastric and testicular oxidative stress in rats. Redox Rep 2001; 6:173-177.
103. BANDYOPADHYAY D, BANDYOPADHYAY A, DAS PK, REITER RJ. Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage. J Pineal Res 2002; 33:1-7.
104. GULTEKIN F, DELIBAS N, YASAR S, KILINC I. In vivo changes in antioxidant systems and protective role of melatonin and a combination of vitamin C and vitamin E on oxidative damage in erythrocytes induced by chlorphyrifos-ethyl in rats. Arch Toxicol 2001; 75:88-96.
105. OZBEK E, TURKOZ Y, SAHNA E et al. Melatonin administration prevents the nephrotoxicity induced by gentamicin. BJU Int 2000; 85:742-746.
106. ONER-IYIDOGAN Y, GURDOL F, ONER P. The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes. Pharmacol Res 2001; 44:89-93.
107. EL-MISSIRY MA. Prophylactic effect of melatonin on lead-induced inhibition of heme biosynthesis and deterioration of antioxidant systems in male rats. J Biochem Mol Toxicol 2000; 14:57-62.
108. ARSLAN SO, ZERIN M, VURAL H, COSKUN A. The effect of melatonin of bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 2002; 32:21-25.
109. CRUZ A, PADILLO FJ, TUNEZ I et al. Melatonin protects against renal oxidative stress after obstructive jaundice in rats. Eur J Pharmacol 2001; 425:135-139.
110. LANKOFF A, BANASIK A, NOWAK M. Protective effect of melatonin against nodularin-induced oxidative stress. Arch Toxicol 2002; 76:158-165.
111. ANWAR MM, MOUSTAFA MA. The effect of melatonin on eye lens of rats exposed to ultraviolet radiation. Comp Biochem Physiol C Toxicol Pharmacol 2001; 129:57-63.
112. SAILAJA DEVI MM, SURESH Y, DAS UN. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 2000; 29:108-115.
113. VURAL H, SABUNCU T, ARSLAN SO, AKSOY N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 2001; 31:193-198.
114. WAHAB MH, AKOUL ES, ABDEL-AZIZ AA. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori 2000; 86:157-162.
115. KAYA H, DELIBAS N, SERTESER M et al. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol 1999; 175:285-288.
116. CLERCH LB, MASSARO D. Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression. J Clin Invest 1993; 91:499-508.
117. ANTOLÍN I, MAYO JC, SAINZ RM et al. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res 2002; 943:163-173.
118. EBISAWA T, KARNE S, LERNER MR, REPPERT SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994; 91:6133-6137.
119. REPPERT SM, WEAVER DR, CASSONE VM et al. Melatonin receptors are for the birds; molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 1995; 15:1003-1015.
120. RAM PT, DAI J, YUAN L et al. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett 2002; 179:141-150.
121. CHAN A, LAI F, LO R et al. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal 2002; 14:249-257.
122. PABLOS MI, GUERRERO JM, ORTIZ GG, AGAPITO MT, REITER RJ. Both melatonin and putative nuclear melatonin receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo. Neuroendocrinol Lett 1997; 18:49-58.
123. VANECEK J. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78:687-721.
124. 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
125. 2+/calmodulin-dependent protein kinase IV. EMBO J 2000; 19:691-701.
126. TANAKA T, KURABAYASHI M, AIHARA Y et al. Inducible expression of manganese superoxide dismutase by phorbol 12-myristate 13-acetate is mediated by Sp1 in endothelial cells. Arterioscler Thromb Vase Biol 2000; 20:392-401.
127. MOHAN N, SADEGHI K, REITER RJ, MELTZ ML. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 1995; 37:1063-1070.
128. GILAD E, WONG HR, ZINGARELLI B et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation. FASEB J 1998; 12:685-693.
129. ROSS AW, BARRETT P, MERCER JG, MORGAN PJ. Melatonin suppresses the induction of AP-1 transcription factor components in the pars tuberalis of the pituitary. Mol Cell Endocrinol 1996; 123:71-80.
130. URATA Y, HONMA S, GOTO S et al. Melatonin induces γ- glutamylcysteine synthetase mediated by activator portein-1 in human vascular endothelial cells. Free Rad Biol Med 1999; 27:838-847.